Diabetic Myonecrosis Presenting with Bilateral Knee Effusion

Poll

A 50-year-old African American woman with type 2 diabetes mellitus and hypertension was admitted with constant bilateral knee and thigh pain and swelling of both knees. Bilateral knee effusions were present. The diagnosis was diabetic myonecrosis. Which statement about this condition is false?

 

 

A 50-year-old African American woman with type 2 diabetes mellitus and hypertension was admitted with constant bilateral knee and thigh pain and swelling of both knees. Bilateral knee effusions were present. The diagnosis was diabetic myonecrosis.
 

Which statement about diabetic myonecrosis is false?

A. It is a rare complication of uncontrolled diabetes mellitus.
B. Elevated C-reactive protein and creatine phosphokinase levels are diagnostic of this complication.
C. Early diagnosis can minimize unnecessary and potentially harmful interventions.
D. It is an indicator of severe microvascular compromise.
Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
Should We Reclassify Diabetes Subtypes?
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
Related Content
Alie Rezaie, MD | Credit: Cedars-Sinai

Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows

Patrick Campbell
July 22nd 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
FDA Issues CRL to Once-Weekly Insulin Icodec | Image Credit: US Food and Drug Administration

FDA Issues Complete Response Letter for Once-Weekly Insulin Icodec

Connor Iapoce
July 11th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Nicholas Stucky, MD, PhD | Credit: LinkedIn

Tirzepatide Bests Semaglutide in Real-World Weight Loss Analysis

Patrick Campbell
July 8th 2024
Article
HCPLive Endocrinology Month In Review June 2024 Thumbnail

Endocrinology Month in Review: June 2024

Patrick Campbell
July 5th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.